Trump Orders Fast-Tracking of Psychedelic Drug Reviews, Including Controversial Ibogaine
U.S. President Donald Trump signed an executive order aimed at accelerating federal review processes for certain psychedelic substances, including Ibogaine, a drug currently classified among the most restricted substances under …
Trump Orders Fast-Tracking of Psychedelic Drug Reviews, Including Controversial Ibogaine Read More